These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9754669)

  • 21. Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous system involvement.
    Jennings FW; Urquhart GM; Murray PK; Miller BM
    Trans R Soc Trop Med Hyg; 1983; 77(5):693-8. PubMed ID: 6659049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of the sleeping sickness trypanosome from chemotherapy by different parts of the brain.
    Raseroka BH; Ormerod WE
    East Afr Med J; 1985 Jul; 62(7):452-8. PubMed ID: 4076024
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice.
    Jennings FW; Urquhart GM
    Z Parasitenkd; 1983; 69(5):577-81. PubMed ID: 6636983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy of chronic trypanosomiasis: the failure of ketoconazole to cure murine infections of Trypanosoma brucei with central nervous system involvement.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1988; 82(2):246. PubMed ID: 3188151
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy of late-stage trypanosomiasis: the effect of the nitrothiazole compounds.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1987; 81(4):616. PubMed ID: 3445346
    [No Abstract]   [Full Text] [Related]  

  • 26. Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion.
    Amin DN; Masocha W; Ngan'dwe K; Rottenberg M; Kristensson K
    Acta Trop; 2008 Apr; 106(1):72-4. PubMed ID: 18329619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An efficacy trial on Trypanosoma brucei brucei of molecules permeating the blood-brain barrier and of megazol].
    Marie-Daragon A; Rouillard MC; Bouteille B; Bisser S; de Albuquerque C; Chauvière G; Périé J; Dumas M
    Bull Soc Pathol Exot; 1994; 87(5):347-52. PubMed ID: 7496199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of 2-substituted 5-nitroimidazoles in the treatment of chronic murine Trypanosoma brucei infections with central nervous system involvement.
    Jennings FW; Urquhart GM; Murray PK; Miller BM
    Z Parasitenkd; 1984; 70(6):691-7. PubMed ID: 6524019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.
    Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis.
    Jennings FW; Ulrich P; Cerami A
    Trop Med Parasitol; 1987 Sep; 38(3):181-6. PubMed ID: 3124253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human African trypanosomiasis: present and future treatment ].
    Dumas M; Bouteille B
    Bull Soc Pathol Exot; 2002 Dec; 95(5):341-4. PubMed ID: 12696372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of late stage rhodesiense trypanosomiasis using suramin and eflornithine: report of six cases.
    Clerinx J; Taelman H; Bogaerts J; Vervoort T
    Trans R Soc Trop Med Hyg; 1998; 92(4):449-50. PubMed ID: 9850406
    [No Abstract]   [Full Text] [Related]  

  • 35. Orchitis as an unusual manifestation of human African trypanosomiasis.
    Ehrhardt S; Lippert U; Burchard GD; Sudeck H
    J Infect; 2006 Jan; 52(1):e31-3. PubMed ID: 15936085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of sleeping sickness. Results in the Tete district].
    Neves J
    An Esc Nacl Saude Publica Med Trop (Lisb); 1970; 4(1):229-47. PubMed ID: 4252881
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of Rhodesian sleeping sickness in Kenya.
    Wellde BT; Chumo DA; Reardon MJ; Abinya A; Wanyama L; Dola S; Mbwabi D; Smith DH; Siongok TA
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():99-109. PubMed ID: 2619399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanocidal activity of a 5-substituted 2-nitroimidazole compound (Ro 15-0216) in mice.
    Zweygarth E; Röttcher D
    Trop Med Parasitol; 1987 Sep; 38(3):171-4. PubMed ID: 3432951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.